Quick Answer
Sensei Biotherapeutics, Inc. reported Total Assets of $22.90 million for the year ending 2025.
- Sensei Biotherapeutics, Inc. showed a decrease of -49.5% in Total Assets from 2024 to 2025.
- This data is from Sensei Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $174.48 million | Q2 2021: $167.72 million | Q3 2021: $161.25 million | Q1 2022: $150.04 million | Q2 2022: $138.04 million | Q3 2022: $128.80 million | Q1 2023: $107.93 million | Q2 2023: $89.58 million | Q3 2023: $81.66 million | Q1 2024: $66.70 million | Q2 2024: $59.80 million | Q3 2024: $53.25 million | Q1 2025: $38.27 million | Q2 2025: $31.78 million | Q3 2025: $27.59 million.
- Over the full 6 years of available data (2020 to 2025), Sensei Biotherapeutics, Inc.'s Total Assets has grown by 6.9%.
- Historical annual values: Fiscal year 2025: $22.90 million | Fiscal year 2024: $45.36 million | Fiscal year 2023: $74.37 million | Fiscal year 2022: $118.38 million | Fiscal year 2021: $153.23 million | Fiscal year 2020: $21.43 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: